BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials.
Last month in BMC Cancer
Are cancer patients better off if they participate in clinical trials?
How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.
Articles
-
-
Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy: evidence from a meta-analysis of randomized control trials
-
The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis
-
Bioinformatics and survival analysis of glia maturation factor-γ in pan-cancers
-
Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis
-
An electronic application for rapidly calculating Charlson comorbidity score
-
Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression
-
Does colon cancer ever metastasize to bone first? a temporal analysis of colorectal cancer progression
-
Atypical glandular cells in conventional cervical smears: Incidence and follow-up
-
M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide
Featured video: Microparticles, breast cancer's secret weapon?
Your browser needs to have JavaScript enabled to view this video
Welcome
Call for Submissions: 'Microbiome and Cancer' Collection
The Editors of BMC Cancer and BMC Microbiology invite of submissions to our ‘Microbiome and Cancer’ cross journal collection. Guest edited by Prof. Christopher Staley and Dr. Sean Devlin. Open for submissions until 1st May 2021.
Support and Guidance
Planning to submit a systematic review?
Prof Kelley provides a practical and stepwise approach for systematically reviewing the literature and publishing the results here.
Submitting a study protocol?
Find out more about the journal's criteria and scope for study protocols here.
BMC Series Focus Issues
April: Our Changing Environment
In preparation for Earth Day on 22nd April, the BMC Series presents a focus issue on Our Changing Environment, highlighting research from across the journals on climate change, conservation, pollution, and the impact of environmental changes on human health and disease.
March: Rare diseases
With the 28th of February marking World Rare Diseases day, the BMC Series this month looks at highlighting research on the Rare diseases that together affect around 10% of the population. Read the full collection of articles here.
Trending BMC Cancer Articles
Click here to view which Articles have been shared most in the last 6 months!
BMC Series Blog
Editorial: Nobel Prize Cancer Immunotherapy!
Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...
Follow
Annual Journal Metrics
-
Speed
79 days to first decision for reviewed manuscripts only
55 days to first decision for all manuscripts
170 days from submission to acceptance
16 days from acceptance to publicationCitation Impact
3.15 - 2-year Impact Factor
3.432 - 5-year Impact Factor
1.021 - Source Normalized Impact per Paper (SNIP)
1.186 - SCImago Journal Rank (SJR)Usage
5,089,371 Downloads
2,117 Altmetric Mentions
